Cargando…
Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
Cis-diamminedichloridoplatinum(II) (CDDP), commonly referred to as cisplatin, is a chemotherapeutic drug used for the treatment of a wide range of solid cancers. CDDP is a relatively poor inducer of immunogenic cell death (ICD), a cell death modality that converts dying cells into a tumor vaccine, s...
Autores principales: | Michaud, Mickaël, Sukkurwala, Abdul Qader, Di Sano, Federica, Zitvogel, Laurence, Kepp, Oliver, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063145/ https://www.ncbi.nlm.nih.gov/pubmed/25050202 http://dx.doi.org/10.4161/onci.28276 |
Ejemplares similares
-
Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
por: Sukkurwala, Abdul Qader, et al.
Publicado: (2014) -
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
por: Michaud, Mickaël, et al.
Publicado: (2012) -
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects
por: Kepp, Oliver, et al.
Publicado: (2012) -
Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020) -
Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus
por: Gomes-da-Silva, Lígia Catarina, et al.
Publicado: (2018)